Sensei Biotherapeutics Company

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

Employee Number: 1-10
Funding Status: IPO
Technology: Small Molecules
Industry: PharmTech
Headquarters: Gaithersburg, Maryland, United States
Estimated Revenue: $1M to $10M